Invention Grant
US08648063B2 Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
失效
7-（2,5-二氢-4-咪唑并[1,2-a]吡啶-3-基-2,5-二氧代-1H-吡咯-3-基）-9-氟-1 ，2,3,4四氢-2-（1-哌啶基 - 羰基） - 吡咯并[3,2,1-jk] [1,4]苯并二氮杂
![Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine](/docs/US/2014-02-11/US08648063B2/abs.jpg.600x600.jpg)
- Patent Title: Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
- Patent Title (中): 7-（2,5-二氢-4-咪唑并[1,2-a]吡啶-3-基-2,5-二氧代-1H-吡咯-3-基）-9-氟-1 ，2,3,4四氢-2-（1-哌啶基 - 羰基） - 吡咯并[3,2,1-jk] [1,4]苯并二氮杂
-
Application No.: US13654884Application Date: 2012-10-18
-
Publication No.: US08648063B2Publication Date: 2014-02-11
- Inventor: Marcio Chedid , Thomas Albert Engler
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent John C Demeter; Robert D Titus
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/33 ; A01N43/62 ; A61K31/55
![Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine](/abs-image/US/2014/02/11/US08648063B2/abs.jpg.150x150.jpg)
Abstract:
An improved method for treating gastric cancer, ovarian cancer, non-small cell lung cancer, or colorectal cancer in a patient is described, as well as pharmaceutical compositions useful for the method and a process for preparing said compositions.
Public/Granted literature
Information query
IPC分类:
